MDxHealth MDxHealth Prices $40M Public Offering The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million. In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More News items for the week of Jan. 9, 2023. In Brief This Week: OpGen, MDxHealth, Dante Genomics, More New items for the week of Oct. 24, 2022. MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay Premium The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points. In Brief This Week: Genetron, MDxHealth, Biocept, Beckman Coulter, Biocartis, Satio, More News items for the week of Aug. 22, 2022. Aug 2, 2022 MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M Jun 17, 2022 Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth Mar 3, 2022 MDxHealth Posts 20 Percent Revenue Growth for 2021 Nov 29, 2021 Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy Nov 12, 2021 In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More Nov 4, 2021 MDxHealth Prices IPO of American Depositary Shares Oct 21, 2021 MDxHealth Q3 Revenues Grow 23 Percent Oct 13, 2021 MDxHealth Files for IPO of American Depositary Shares Sep 1, 2021 MDxHealth Files for IPO of American Depositary Shares Aug 26, 2021 MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Mar 3, 2021 MDxHealth 2020 Revenues Up 57 Percent Mar 2, 2021 Oppenheimer Initiates Coverage of MDxHealth at Outperform Oct 21, 2020 MDxHealth Q3 2020 Revenues Drop 6 Percent Aug 26, 2020 MDxHealth H1 2020 Revenues Down 9 Percent on Declining Test Volumes Apr 27, 2020 MDxHealth Receives €12.7M Investment From MVM Partners Apr 9, 2020 MDxHealth Q1 Revenues Up 24 Percent; Company Suspends 2020 Guidance Feb 26, 2020 MDxHealth 2019 Revenues Fall 58 Percent Nov 11, 2019 MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period Oct 4, 2019 Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.